abstract |
Disclosed is an association, which is rosiglitazone and coenzyme Q10. Also disclosed is the use of the above association in obtaining pharmaceutical compositions intended for the treatment and/or prevention of obesity, specifically obesity that was caused by a therapeutic treatment such as the treatment of type I or II diabetes. (62) Divided Out of 539331 |